Global Markets for Allergy Diagnostics and Treatments

Report Code: PHM026D

Publish Date: Jun 2025

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

30% Off

Limited Period Offer

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

Report Includes

  • 161 data tables and 54 additional tables
  • Analyses of the trends in global markets for allergy diagnostics, immunotherapy and treatments, with revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
  • Estimates of the size and revenue prospects for the global market, along with a market share analysis by type, diagnostic type, treatment type, allergen type, drug type, route of administration, and region
  • Facts and figures pertaining to the market dynamics, new developments in diagnostic testing, advances in treatments, new regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain analyses
  • Evaluation of recent patent activity and key granted and published patents
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
  • Analysis of the industry structure, including companies’ market shares, strategic alliances, M&A activity, venture fundings and investment outlook
  • Profiles of leading companies, including ALK-Abelló A/S, Stallergenes Greer, GSK plc., AbbVie Inc., and AstraZeneca

Report Scope

This report will provide detailed information on allergy diagnostics and treatments. It analyzes the market trends, with the base year for the study being 2024. It provides estimates for 2025, and forecasts for 2025 through 2030, including the compound annual growth rate (CAGR) for the forecast period. It also analyzes regional markets. This report will highlight allergy diagnostics, current and future market potential of treatments, and a detailed competitive environment analysis. The report will cover regulatory scenarios, drivers, restraints, and opportunities. Also included will be market shares for key players.

The market is segmented into two major categories: diagnostics and treatments. Diagnostics include skin testing (prick, patch, intradermal) and blood testing (antibody). Treatments include antihistamines, sympathomimetics, decongestants and combinations, corticosteroids, leukotrienes, mast cell stabilizers, immunotherapy, and others. Immunotherapy is further segmented into subcutaneous administration, sublingual liquid solutions, and sublingual tablets. The treatments market is segmented into food, drug, inhaled, and others based on allergen type. Drug types are market segmented into prescription drug and over-the-counter (OTC).

The allergy diagnostics and treatment market has been segmented into North America, Europe, the Asia-Pacific, the Middle East and Africa (MEA), and South America. The detailed regional analysis will cover major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data will be provided with 2024 as the base year.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $63.5 Billion
Market size forecast $96.4 Billion
Growth rate CAGR of 7.3% from 2025 to 2030
Units considered $ Millions
Segments covered By Type, Diagnostic Type, Treatment Type, Allergen Type, Drug Type, Drug Route of Administration, and Region
Regions covered North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)
Countries covered U.S., Canada, Mexico, Brazil, Argentina, Germany, the U.K., France, Italy, Spain, Rest of Europe, Japan, China, India, South Korea, Australia, Rest of Asia-Pacific, the Middle East, Africa, and Rest of South America
Key Market Drivers
  • Novel advances in allergy diagnosis and treatment.
  • Increasing cases of allergies worldwide.
  • Robust pipeline of allergy medications.
Companies studied
ABBVIE INC.ALK
AMGEN INC.ASTRAZENECA
BAYER AGF. HOFFMANN-LA ROCHE LTD.
GSK PLC.LILLY
NOVARTIS AGPFIZER INC.
REVVITYSANOFI
STALLERGENES GREERTHERMO FISHER SCIENTIFIC INC.
VIATRIS INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global allergy diagnostic and treatment market was valued at $63.5 billion in 2024 and is expected to reach $96.4 billion by the end of 2030, growing at a CAGR of 7.3% during the forecast period.
The novel advances in allergy diagnosis and treatment, increasing cases of allergies worldwide, and recent product launches in the allergy market were reviewed to understand the market dynamics and trends for forecasting the market size.
The market scope in this report is segmented into major types: diagnostics and treatments. The market is segmented into diagnostics, such as skin testing (prick, patch, intradermal) and blood testing (antibody). Based on treatments, the report covers antihistamines, sympathomimetics, decongestants and combinations, corticosteroids, leukotrienes, mast cell stabilizers, immunotherapy, and others. The immunotherapy is further segmented into subcutaneous administration, sublingual liquid solutions, and sublingual tablets. The market is segmented into food, drug, inhaled, and others based on allergen type. Based on drug type, the market is segmented into prescription and OTC.
Antihistamines dominate the market, but Immunotherapy will grow in the allergy diagnostic and treatment market.
The North American market for allergy diagnostics and treatments was valued at $37.1 billion in 2024 and is estimated to reach $56.7 billion in 2030, at a CAGR of 7.4% during the forecast period. North America had a 58.4% share of the global market in 2024.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Allergy Diagnostics and Treatments194Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview5Free
Chapter- 3: Market Dynamics5Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Emerging Technologies4Free
Chapter- 6: Market Segmentation Analysis108Free
Chapter- 7: Competitive Intelligence4Free
Chapter- 8: Sustainability in the Allergy Diagnostics and Treatment Market: ESG Perspective3Free
Chapter- 9: Appendix56Free

Related Reports

In Vitro Diagnostics: Technologies and Global Markets

Published - Jan 2025 | Publisher - Partha Sarathi Das | Code - HLC186D

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

OTC Drugs, Medical Devices and Diagnostics: Global Markets

Published - Jan 2025 | Publisher - BCC Publishing | Code - HLC251B

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

Global Skin Allergy Testing Market

Published - May 2024 | Publisher - BCC Publishing | Code - MDS104A

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

Immunotherapy Drugs: Global Markets

Published - Apr 2021 | Publisher - BCC Publishing | Code - PHM249A

The global market for immunotherapy drugs should grow from $139.8 billion in 2020 to $204.4 billion by 2025, at compound annual growth rate (CAGR) of 7.9% for the period of 2020-2025.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 215

  • Summary Table: Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
  • Table 1: Recent Clinical Drug Trials
  • Table 2: Difference in the U.S. and European Regulatory Landscapes
  • Table 3: Examples of Clinical Trials in Allergy Drug Development
  • Table 4: Allergy Diagnostics and Treatments Patent Analysis, 2025
  • Table 5: Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
  • Table 6: Global Market for Allergy Diagnostics, by Diagnostic Type, Through 2030
  • Table 7: Global Market for Allergy Diagnostics, by Region, Through 2030
  • Table 8: Global Market for Allergy Treatment, by Treatment Type, Through 2030
  • Table 9: Global Market for Allergy Treatment, by Immunotherapy Type, Through 2030
  • Table 10: Global Market for Other Allergy Treatments, by Region, Through 2030
Sample Report

Recent Reports

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM026D

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - PHM050D

The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

The Global Influenza Market

Published - May 2025 | Publisher - BCC Publishing | Code - PHM049F

The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029. 

Liver Disease Treatments: The Global Market

Published - Apr 2025 | Publisher - BCC Publishing | Code - PHM057D

The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.

Top Trending Reports

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Jun-2017| Analyst - Vijay Laxmi| Code - PHM026C

Report Highlights

The global allergy diagnostic and treatment market reached nearly $35.3 billion in 2015. This market is expected to increase from nearly $40.0 billion in 2016 to $52.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.9% for 2016-2021.

Report Includes

  • An overview of the global markets for allergy diagnostics and treatments.
  • Analyses of global market trends, with data from 2015 and 2016, and projections of CAGRs through 2021.
  • Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
  • Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
  • Profiles of major players in the allergy diagnostics and treatments industry.
Published - Feb-2015| Analyst - Peggy Lehr| Code - PHM026B

Report Highlights

Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.

Report Includes

  • An overview of the global markets for allergy diagnostics and treatments.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
  • Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
  • Profiles of major players in the allergy diagnostics and treatments industry.

Published - Jun-2002| Analyst - Mary Anne Crandall| Code - PHM026A

Report Highlights

  • The total, current U.S. prescription allergy treatment and management market in 2001 generated revenues of $6.45 billion. In 2006, this market is forecast to reach $9.6 billion, rising at an average annual growth rate (AAGR) of 8.3%.
  • The antihistamines and combinations segment reached $2.90 billion in 2001, some 45% of the market. Growing at an AAGR of 6.7%, this segment will reach $4 billion in 2006, but will lose ground to corticosteroids.
  • Corticosteroids are expected to rise the fastest, at an AAGR of 11.8% to $3.98 billion in 2006, representing 41.5% of the market at that time.
  • The mast cell stabilizers segment will be the second fastest growing and will rise at an AAGR of 8.9% from $340 million in 2001 to $520 million in 2006.
  • Sympathomimetics, decongestants and combinations were valued at $930 million in 2001 and will rise at an AAGR of only 3.2% to $1.09 billion in 2006.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Allergy Diagnostics and Treatments
Sample Report